Kyverna Therapeutics, Inc.KYTXNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
12.58%
↑ 100% above average
Average (11q)
-8986.20%
Historical baseline
Range
High:99.87%
Low:-107804.69%
Volatility
-1200.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 12.58% |
| Q2 2025 | 5.72% |
| Q1 2025 | -19.06% |
| Q4 2024 | -8.69% |
| Q3 2024 | -19.75% |
| Q2 2024 | -107804.69% |
| Q1 2024 | 99.87% |
| Q4 2023 | -33.64% |
| Q3 2023 | -18.13% |
| Q2 2023 | -17.48% |
| Q1 2023 | -31.16% |
| Q4 2022 | 0.00% |